Similar to endocrine-sensitive breast cancer cells, c-Src plays a critical role in the mediation of non-genomic pathways of the ER activated by E2, as well as by EDC in the LTED breast cancer cells (47) (Figure 1). Here, SRC is linked to breast carcinoma.